Stock Analysis on Net
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

$24.99

Common-Size Balance Sheet: Assets
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Bristol-Myers Squibb Co., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash and cash equivalents
Marketable debt securities
Receivables
Inventories
Other current assets
Current assets
Property, plant and equipment
Goodwill
Other intangible assets
Deferred income taxes
Marketable debt securities
Other non-current assets
Non-current assets
Total assets

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The asset structure of the organization exhibits a strategic shift toward higher liquidity and a reconfiguration of non-current assets over the observed period from March 2021 to June 2026. A general trend of increasing current assets as a percentage of total assets is evident, while the proportion of non-current assets has experienced a corresponding decline.

Liquidity and Current Asset Composition
Current assets rose from 24.11% of total assets in March 2021 to 32.61% by June 2026. This growth was primarily driven by fluctuations in cash and cash equivalents, which reached a peak of 16.23% in September 2025 before settling at 9.95% in June 2026. Receivables showed a consistent upward trend, increasing from 7.70% in early 2021 to a peak of 12.68% in December 2025, indicating a larger portion of total assets is tied up in credit sales. Inventories remained a small but growing component, rising slightly from 1.74% to 3.12% over the period.
Intangible Assets and Goodwill
The most significant structural change occurred within the non-current asset category. Other intangible assets saw a substantial and sustained decrease, falling from 45.20% of total assets in March 2021 to 19.84% by June 2026. Conversely, goodwill increased steadily from 18.25% to 24.81% during the same timeframe. This suggests a shift in the composition of intangible value, potentially reflecting the amortization of specific intangible assets alongside the acquisition of new entities that increased goodwill.
Fixed Assets and Deferred Taxes
Property, plant, and equipment (PP&E) demonstrated a gradual increase in its share of total assets, moving from 5.13% in March 2021 to 8.89% in June 2026, indicating expanded investment in physical infrastructure. Additionally, deferred income taxes grew significantly as a percentage of total assets, rising from 0.71% to 6.12%, suggesting a change in the timing of tax recognition relative to accounting profit.

Overall, the balance sheet has transitioned from being heavily dominated by other intangible assets to a more diversified structure with increased weight in current assets, goodwill, and fixed assets. The increase in the current asset ratio suggests an improvement in the short-term liquidity profile of the company.